// App-Quantinova.ai

AEP184 : Free 25-hydroxyvitamin D, but not free 1.25-dihydroxyvitamin D, predicts all-cause mortality in ageing men

Researchers

Presenter

  • Leen Antonio

Principal Investigators

  • Marian Dejaeger

  • Roger Bouillon

  • Frederick Wu

  • Terence ONeill

  • Stephen Pye

  • Ilpo Huhtaniemi

  • Giulia Rastrelli

  • Gianni Forti

  • Felipe Casanueva

  • Jolanta Slowikowska-Hilczer

  • Margus Punab

  • Jos Tournoy

  • Dirk Vanderschueren

Medical Centers

  • Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), Laboratory of Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium

  • University Hospitals Leuven, Department of Abdominal Surgery, Leuven, Belgium

  • KU Leuven, Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium

  • University of Leuven, Department of Pediatrics, Leuven, Belgium

  • The University of Manchester, Andrology Research Unit, Centre for Endocrinology & Diabetes, Institute of Human Development, Manchester, United Kingdom

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • Imperial College London, Department of Metabolism Digestion and Reproduction, London, United Kingdom

  • University of Florence, Andrology Unit, Florence, Italy

  • Universidad de Santiago de Compostela, Department of Medicine, Santiago de Compostela, Spain

  • Medical University of Łódź, Department of Andrology and Reproductive Endocrinology, Łódź, Poland

  • Tartu University, Andrology Unit, Tartu, Estonia

  • KU Leuven, Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium

Locations

  • Belgium

  • United Kingdom

  • Italy

  • Spain

  • Poland

  • Estonia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • GC Vitamin D Binding Protein

Drug/Treatment

  • Ergocalciferol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved